Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |